Medicare drug price negotiations may have a muted impact on drugmakers in the near term

Many of the drugs are already facing strong competition from other branded medications or patent expirations that will open the market to generic alternatives. 

Previous post Bitcoin Cash price outlook: Sellers pounce after BCH spike above $220
Next post : Apple testing use of 3D printers for future smartwatch cases: report